Calithera Biosciences, Inc.
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company…
Biotechnology
US, South San Francisco [HQ]
Cash Flow Statements
11 Records · Starting from 2012In Million USD. Margins, Growth Rates In %
| Metric | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Cash Flow (OCF) | -6.00 | -11.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Operating Cash (Net) | -6.00 | -11.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other WC | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Investing Activities | ||||||||||||
| Used Cash (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Capital Expenditure | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Investing Activities | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Financing Activities | ||||||||||||
| Used Cash (Net) | -5.00 | -43.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 5.00 | 43.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Cash Balances | ||||||||||||
| Begin of Period | 3.00 | 2.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| End of Period | 2.00 | 33.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -1.00 | 31.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Non-Cash Balances | ||||||||||||
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Stock Based Compensation | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Highlighted metrics | ||||||||||||
| Free Cash Flow (FCF) | -7.00 | -12.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |